The Jasper alternative for Account-Based Marketing in Medical Devices & MedTech

The Account-Based Marketing challenge in Medical Devices & MedTech

Medical device companies market at the intersection of clinical evidence, regulatory clearance, and hospital purchasing committee politics — a cleared device with no clinical champion, no reimbursement code, and no GPO contract is essentially unmarketed regardless of its technical merit.

On Account-Based Marketing specifically, Medical Devices & MedTech teams need Build and maintain a tiered target account list (Tier 1/2/3) using ICP scoring against CRM and third-party data; Monitor target account engagement signals: ad impressions, website visits, content downloads, intent spikes — all tuned to Medical Devices & MedTech channels (Clinical specialty society conferences (ACC, ASN, AAOS, AANS, SAGES, DDW — by clinical specialty), Medical device trade publications (MedCity News, MassDevice, Fierce Medtech, Medical Design & Outsourcing), LinkedIn (CMO or Chief Medical Officer at health systems, OR/cath lab directors, surgeon KOLs, Hospital Value Analysis Coordinator), GPO marketing programs (Vizient, Premier, HealthTrust preferred vendor marketing channels), Clinical society exhibit halls and physician education programs (CME-supported symposia around major meetings)) under FDA 21 CFR Part 807 (510(k) clearance process); FDA 21 CFR Part 814 (PMA process for Class III devices); FDA Off-Label Promotion prohibition (device labeling and promotion must match cleared indications); Physician Payments Sunshine Act (Open Payments) reporting for physician KOL relationships; Anti-Kickback Statute implications for device incentives; HIPAA for any patient data used in clinical studies; EU MDR (Medical Device Regulation) and IVDR for European device marketing; ISO 13485 quality system certification as marketing credibility signal; GDPR for clinical study and registry data involving EU patients. That's a level of channel-specific execution that generic AI writing tools like Jasper are not built to deliver.

Why Medical Devices & MedTech teams choose Hadrian over Jasper for Account-Based Marketing

Marketing teams that need live performance data, paid media agents, attribution, and content working together in one system — the full marketing org, not just the content function. Hadrian's ABM Agent reads CRM account records (industry, ARR, headcount, deal stage, last activity), Intent data (Bombora, 6sense — topic surge by account domain) and produces Tiered target account list (refreshed monthly, scored, with rationale), Account engagement heatmap (by tier and stage — weekly), Personalized account assets (landing pages, one-pagers, email sequences) — continuously, on your Medical Devices & MedTech brand data.

When Jasper is the right fit: Teams whose primary need is high-volume, brand-safe AI copywriting and content pipelines. Jasper's brand voice governance (Jasper IQ), 900+ enterprise clients, and Forrester-validated ROI make it the safest enterprise content tool available.. For Medical Devices & MedTech teams that need Account-Based Marketing running in the background — not on-demand prompting — Hadrian is purpose-built.

Account-Based Marketing outputs Hadrian delivers for Medical Devices & MedTech teams

AI monitors engagement signals across hundreds of target accounts simultaneously and drafts personalized assets per account — humanly impossible to do at this scale without a large ABM team. For Medical Devices & MedTech, that means Tiered target account list (refreshed monthly, scored, with rationale), Account engagement heatmap (by tier and stage — weekly), Personalized account assets (landing pages, one-pagers, email sequences), ABM pipeline report (account-attributed pipeline by tier, quarterly) tuned to Medical Devices & MedTech buyers (VP Marketing or VP Commercial at a medical device manufacturer (Series C through public); Product Manager responsible for a specific device line; VP Sales or National Accounts Director managing GPO relationships and IDN accounts; at health systems, a Value Analysis Coordinator or Director of Supply Chain evaluating device portfolios; Interventional Cardiologist, Orthopedic Surgeon, or specialty physician as clinical evaluator and champion) and channels: Clinical specialty society conferences (ACC, ASN, AAOS, AANS, SAGES, DDW — by clinical specialty), Medical device trade publications (MedCity News, MassDevice, Fierce Medtech, Medical Design & Outsourcing), LinkedIn (CMO or Chief Medical Officer at health systems, OR/cath lab directors, surgeon KOLs, Hospital Value Analysis Coordinator), GPO marketing programs (Vizient, Premier, HealthTrust preferred vendor marketing channels), Clinical society exhibit halls and physician education programs (CME-supported symposia around major meetings). These move Target account pipeline coverage (% of Tier-1 accounts with open opportunity), Account engagement rate (% of target accounts with 2+ marketing touches/month), ABM-attributed pipeline velocity (days from first touch to SQL for target accounts) — the metrics Medical Devices & MedTech marketing teams are accountable for.

RELATED